Cleveland.com: Ventilator shortage during coronavirus? 3-D printing could save lives
UC anesthesiologist discusses ventilators
Imagine printing a three-dimensional piece of plastic that could help save a coronavirus patient’s life. 3-D printing is one solution proposed to address an expected shortage of ventilators, machines that keep patients whose lungs are severely damaged alive. Experts are expecting a shortages of ventilators as the number of people impacted by the coronavirus pandemic grows in the U.S.
Ventilators work through a breathing tube inserted into a person’s windpipe. The machine inflates the lungs with air and then deflates the lungs, removing carbon dioxide. A medical professional uses a computer to control the amount of pressure placed on the lungs and the amount of oxygen.
Coronavirus patients are at risk of pneumonia and acute respiratory distress syndrome, which has a high mortality rate. Dr. Suzanne Bennett, an associate professor at the UC College of Medicine and an anesthesiologist at UC Health, discussed the workings of ventilators.
A traditional ventilator costs about $25,000 to $50,000. Bennett said some of the “bells and whistles" on a hospital-grade ventilator help medical professionals operate the machine effectively, and reduce the workload for respiratory therapists. With a shortage, respiratory therapists would be spread thin.
“I think all of us are concerned with the safety of that patient in that situation,” she said.
Related Stories
Cancer Center expert urges lung cancer screenings as too few at-risk patients get tested
September 4, 2026
The University of Cincinnati Cancer Center's Robert Van Haren, MD, spoke with Local 12 about the need for more awareness and discussions around lung cancer screenings.
Apply for 2027 Presidential Medal Awards
September 4, 2026
UC President Neville Pinto invites eligible students to apply for two of our university’s top awards — the PLME & PMGSE.
Selecting noninvasive tests for liver disease diagnosis, monitoring
September 3, 2026
Noninvasive tests have emerged as valuable alternatives for diagnosing, staging and monitoring MASLD and MASH, according to a recent MedCentral report.